U.S. and Pfizer Are Negotiating Deal for More Vaccine Doses Next Year
By admin | December 15, 2020 | AstraZeneca PLC, Coronavirus (2019-nCoV), Covid-19 Coronavirus, Drugs (Pharmaceuticals), European Union, Food and Drug Administration, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Company Inc, Moderna Inc, Oxford University, Pfizer Inc, Sanofi SA, United States Politics and Government, Vaccination and Immunization | 0 Comments
The Trump administration is discussing helping the drug maker get the raw materials it would need to produce tens of millions of extra doses of its Covid-19 vaccine in the spring.